KOSPIChemicals003080

Sbsungbo

₩2,140▼ 0.70%2026-11-18 close
Market Cap
₩42.8B
Turnover
₩27,499,950
Volume
10K
Shares out.
20M
PER
—
PBR
0.3×
EPS
-₩651
Dividend Yield
9.53%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩205 per share · Prices as of the 2026-11-18 close

01

Report overview

Crop-protection focused Sbsungbo: losses continue in recent quarters

Sbsungbo is a small chemical maker whose crop-protection products account for more than 95% of sales, and whether its operating profit can hold positive after losses returned in the last two quarters remains the key point to track.

  1. 1

    Sales rose 7.5% to KRW 64.3 billion in 2025, but the operating loss widened to KRW 8.14 billion, leaving the company in the red for two straight years from 2024 to 2025.

  2. 2

    The KRW 34.5 billion controlling-shareholder net profit in 2025 came from a larger gain on the sale of the headquarters building, so an operating loss and a net profit appeared in the same year.

  3. 3

    Operating profit of KRW 7.05 billion in Q1 2026 gave way to operating losses of KRW 3.67 billion in Q2 and KRW 3.92 billion in Q3, a two-quarter run of losses.

  4. 4

    The debt ratio fell to 49.4% at the end of 2025 from 73.0% in 2024, with total equity at KRW 152.8 billion and total liabilities at KRW 75.5 billion.

  5. 5

    Controlling-shareholder net losses over the last four quarters total KRW 12.8 billion, and operating cash flow was negative in each of the four years from 2022 to 2025.

02

Business structure

Sbsungbo is a KOSPI-listed chemical company whose main business is manufacturing and selling crop protection products, or agrochemicals. As of the third quarter of 2025, crop protection products accounted for 95.42% of total sales, with rental income and cafe sales making up the rest.

Its main product lines are insecticides, fungicides and herbicides, and the company says it aims to strengthen external competitiveness through quality improvements and new product development.

Sales run through a network of regional sales branches, and its main customers are wholesalers and retailers that serve farmers. Revenue is concentrated in the spring and summer seasons, so quarterly results can swing widely.

On the competitive front, intensifying market competition driven by agricultural import liberalization and the opening of imports of crop protection active ingredients is cited as a key pressure.

In 2025 the company said a sharp rise in the exchange rate lifted manufacturing costs, which suggests its cost structure is sensitive to currency moves.

On the production side, the company has pursued the prevention of serious industrial accidents and stronger safety in chemical handling as core tasks since 2022, and it ranked first in a 2025 chemical safety best-practice contest.

Rental and cafe operations provide revenue beyond crop protection, but their scale is small relative to crop protection. The largest shareholder and related parties hold 48.62%, a figure last changed on December 20, 2022, so the ownership structure is concentrated.

Compared with large chemical companies such as LG Chem and Hanwha Solutions, the company's portfolio is concentrated in a single crop-protection line.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩6.7B-₩4.8B−71.2%
2025Q4₩1.7B-₩7.4B−425.4%
2026Q1₩44.3B₩7B15.9%
2026Q2₩12.9B-₩3.7B−28.4%
2026Q3₩7.6B-₩3.9B−51.7%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩66.4B₩1.9B₩4B2.9%2.9%24.3%
2023₩62.6B₩200M₩1.3B0.3%1.0%25.0%
2024₩59.8B-₩2.9B-₩3.4B−4.9%−2.7%73.0%
2025₩64.3B-₩8.1B₩34.5B−12.7%22.4%49.4%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

On the DART-filed annual figures, sales fell from KRW 66.4 billion in 2022 to KRW 62.6 billion in 2023, a 5.7% decline, and then to KRW 59.8 billion in 2024, a 4.4% decline, before rising 7.5% to KRW 64.3 billion in 2025. 2022 was the largest year and 2024 the smallest within the 2022 to 2025 window.

Operating profit dropped from KRW 1.9 billion in 2022 to KRW 201 million in 2023, an 89.4% decline, and then turned into an operating loss of KRW 2.93 billion in 2024. The 2025 operating loss widened to KRW 8.14 billion, which makes 2024 and 2025 two consecutive loss years.

Operating margin moved from 2.9% in 2022 to 0.3% in 2023, -4.9% in 2024 and -12.7% in 2025. The company attributed the 2025 widening to higher manufacturing costs from a sharp rise in the exchange rate and to one-time costs tied to the headquarters relocation.

Controlling-shareholder net profit, by contrast, swung from a KRW 3.44 billion net loss in 2024 to a KRW 34.5 billion profit in 2025, which the company linked to a larger gain on the sale of the headquarters building.

Net income including non-controlling interests was KRW 34.1 billion, a different figure from the controlling-shareholder number, and the combination explains why an operating loss and a net profit appeared in the same year.

On a quarterly basis, the company moved from an operating loss of KRW 7.41 billion in Q4 2025 to operating profit of KRW 7.05 billion in Q1 2026, but operating losses of KRW 3.67 billion in Q2 2026 and KRW 3.92 billion in Q3 2026 followed.

Q3 2026 sales of KRW 7.57 billion rose 12.6% from a year earlier, and the operating loss narrowed from the year-earlier quarter. Net losses attributable to controlling shareholders over the last four quarters total KRW 12.8 billion.

Operating cash flow was negative in every year, at -KRW 3.66 billion in 2022, -KRW 1.78 billion in 2023, -KRW 3.26 billion in 2024 and -KRW 6.05 billion in 2025.

05

Industry analysis

Demand for crop protection products follows the farming calendar, so Sbsungbo's sales are concentrated in the spring and summer seasons. On the market side, the expansion of agricultural import liberalization has put pressure on domestic selling prices and volumes, a point the company's own materials repeatedly raise.

The import liberalization of crop protection active ingredients is also cited as widening raw material sourcing routes and intensifying competition. Because raw material and manufacturing costs are exposed to exchange rates, the company said a sharp rise in the exchange rate lifted manufacturing costs in 2025.

The company presents its network of regional sales branches as a competitive tool and positions quality improvements and new product development as ways to differentiate.

Large companies in the same chemical sector run several businesses, including petrochemicals, battery materials and high-value materials, so their business mix differs sharply from Sbsungbo's crop-protection focus.

The company attributes the 2025 earnings swing to a combination of the currency rise and one-time items tied to the headquarters relocation and sale. Within the competitive landscape, Sbsungbo sits as a small specialist operator that relies on its branch sales network and product quality.

06

Outlook

The next periodic report on the DART filing schedule is the 2026 annual report, which will confirm the full-year operating margin and the fourth-quarter 2026 results. Operating losses continued in Q2 and Q3 2026, and the Q4 2026 results have not yet been disclosed.

Sales peaked at KRW 44.3 billion in Q1 2026 and then fell to KRW 12.9 billion in Q2 and KRW 7.57 billion in Q3. Because crop protection sales concentrate in the spring and summer, sales and cost ratios in the 2027 spring season will shape the next phase of results.

Whether the effect of the exchange rate on manufacturing costs persists after 2026 will show up in the cost ratio. The gain on the headquarters building sale is a one-time item, so reading the net profit trend alongside operating results is consistent with the company's own explanation.

The company's annual dividend for the most recent completed year rose from the prior year, based on kpinfo data as of September 14, 2026. The next checkpoints are the full-year operating margin in the 2026 annual report and whether operating profit turns positive again in the Q1 2027 quarterly report.

07

Valuation

PER
—
PBR
0.3×
ROE
-8.0%
EPS
-₩651
BPS
₩7,607
Dividend per share
₩205

The price-to-book ratio sits below 1x and below the company's own five-year average. Market capitalization is small relative to total equity of KRW 152.8 billion, so the gap between asset value and market valuation is wide, a fact-based comparison.

Because net losses have continued over the last four quarters, the price-to-earnings ratio cannot be calculated. On an annual basis, controlling-shareholder net profit turned positive in 2025, but the filing ties this to the gain on the headquarters building sale, so it should be separated from operating profitability.

Dividend metrics move with the share price, so they are best read alongside the past dividend trend. In a range where the price-to-book ratio is low, the key variable is which earnings trend the share price reflects relative to asset value.

Because operating results swing between profit and loss from quarter to quarter, the range of market assessments of the earnings base can be wide.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Operating profit returned in Q1 2026

Operating profit in Q1 2026 was KRW 7.05 billion, a return to profit, and controlling-shareholder net profit was KRW 4.67 billion. Q3 2026 sales of KRW 7.57 billion rose 12.6% from a year earlier, so the revenue base has been maintained. The operating loss in Q3 2026 was also smaller than in the year-earlier quarter. Whether profitable quarters repeat will be shown by later quarterly results.

Lower financial burden

The debt ratio fell to 49.4% at the end of 2025 from 73.0% in 2024, with total liabilities of KRW 75.5 billion and total equity of KRW 152.8 billion. Controlling-shareholder equity of KRW 153.6 billion supports the capital base. The lower debt ratio points to a smaller borrowing burden. The sale of the headquarters building also reshaped the asset structure.

Rising dividend trend

According to kpinfo data as of September 14, 2026, the annual dividend for the most recent completed year rose 51.85% from the prior year. The increase points to a shift in shareholder return direction.

The dividend was set while operating losses were continuing, so its sustainability will be read alongside later results. Dividend metrics change with the share price.

09

Bear factors

Persistent operating losses

The operating margin was -4.9% in 2024 and -12.7% in 2025, both negative. Operating losses continued in Q2 and Q3 2026, so quarterly losses are recurring. As net losses accumulate, the share attributable to controlling shareholders keeps shrinking. The Q3 2026 operating loss was smaller than a year earlier, but losses continued.

Cost and currency pressure

The company cited higher manufacturing costs from a sharp exchange rate rise as a main driver of the 2025 operating loss. Operating cash flow was negative in each year from 2022 to 2025, and the 2025 outflow of KRW 6.05 billion was the largest. Weak cash generation is linked to the cost burden. Whether the currency pressure persists after 2026 is the key question.

Competition and seasonality

Intensifying competition from agricultural import liberalization and the opening of crop protection active ingredient imports is cited as a key risk. Sales concentrate in the spring and summer, which makes quarterly results volatile. Q2 2026 sales of KRW 12.9 billion fell 70.9% from Q1 2026's KRW 44.3 billion. With a seasonal structure, quarterly results alone make trends difficult to read.

10

Risk factors

Market competition and import rules

Agricultural import liberalization and the opening of active ingredient imports are structural factors that can pressure domestic selling prices and market share. The company said it is responding through quality improvements and new product development.

As competition intensifies, the efficiency of the regional sales branch network becomes more important. Crop protection makes up more than 95% of sales, so changes in competition for this one business flow directly into total results.

Exchange rate and cost

In 2025 the company said a sharp rise in the exchange rate lifted manufacturing costs. If cost increases cannot be passed on to selling prices, the operating margin falls. The 2025 operating margin was -12.7%. How currency moves are reflected in the cost ratio after 2026 is the next key question.

Reliance on one-off gains

The 2025 controlling-shareholder net profit of KRW 34.5 billion was supported by a larger gain on the sale of the headquarters building. Because this item does not recur, the net profit is hard to read as operating profitability.

One-time costs from the headquarters relocation also widened the operating loss in the same year. When one-off items drive results, quarterly volatility increases.

11

What to watch next

  1. December 31, 2026 (fiscal year-end)

    Year-end results and any dividend-related disclosures for fiscal 2026 follow from this date. Whether Q4 2026 operating results match the losses seen in Q2 and Q3 is the next point to check.

  2. March 31, 2027 (filing deadline for the 2026 annual report)

    The 2026 annual report will confirm the full-year operating margin and fourth-quarter net profit attributable to controlling shareholders. It can be compared with the 2025 operating margin of -12.7%.

  3. March to May 2027 (spring sales season)

    This is the concentrated sales period for crop protection products, and sales volume and currency-affected costs will shape later quarterly revenue and operating results. Because of seasonality, this season's outcome is central to interpreting Q1 2027.

  4. May 15, 2027 (filing deadline for the Q1 2027 quarterly report)

    This is the point to check whether operating profit turns positive again after losses in Q2 and Q3 2026. The key question is whether the KRW 7.05 billion operating profit of Q1 2026 can be repeated.

12

Overall view

Sbsungbo is a small chemical company that depends on crop protection sales. Sales rose in 2025, but the operating loss widened and the company recorded a second straight year of losses.

The 2025 turn to a controlling-shareholder net profit reflects a large gain on the sale of the headquarters building and is separate from a recovery in operating profitability.

Operating profit turned positive in Q1 2026, but operating losses returned in Q2 and Q3, and controlling-shareholder net losses over the last four quarters total KRW 12.8 billion. The financial structure improved, with the debt ratio falling to 49.4% in 2025 from 73.0% in 2024.

On the other hand, operating cash flow was negative in every year from 2022 to 2025, and the operating margin was -12.7% in 2025. Strengths include the easing of the financial burden, the Q1 2026 return to operating profit and the rising dividend trend.

Weaknesses include continued operating losses, cost and competition pressure from currency moves and import opening, and earnings volatility from seasonality. The next checkpoints are the full-year operating margin in the 2026 annual report and whether operating profit turns positive in the Q1 2027 quarterly report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. vegannews.co.kr
  2. comp.fnguide.com
  3. digitaltoday.co.kr
  4. goinsider.kr
  5. kpinfo.kr
  6. m.news.nate.com
  7. accidentalorder.com
  8. valueline.co.kr
  9. markets.hankyung.com
  10. sentv.co.kr
  11. pflow.keywordegg.com
  12. news.samsung.com
  13. news.samsung.com
  14. news.samsungsemiconductor.com
  15. news.samsung.com
  16. kr.investing.com
  17. kr.investing.com
  18. welfarehello.com

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis